Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen
about
Genome-wide prediction and validation of peptides that bind human prosurvival Bcl-2 proteinsCharacterization of fortilin, a novel antiapoptotic proteinATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage responseProliferating cell nuclear antigen acts as a cytoplasmic platform controlling human neutrophil survivalMtd/Bok takes a swing: proapoptotic Mtd/Bok regulates trophoblast cell proliferation during human placental development and in preeclampsiaPhysical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperoneTankyrase 1 interacts with Mcl-1 proteins and inhibits their regulation of apoptosisA proteomics approach to identify proliferating cell nuclear antigen (PCNA)-binding proteins in human cell lysates. Identification of the human CHL12/RFCs2-5 complex as a novel PCNA-binding proteinThr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancerProliferating cell nuclear antigen (PCNA) interactions in solution studied by NMRPan-Bcl-2 inhibitor obatoclax delays cell cycle progression and blocks migration of colorectal cancer cellsBim nuclear translocation and inactivation by viral interferon regulatory factor.MCL-1 localizes to sites of DNA damage and regulates DNA damage responseMyeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer.Changes in gene expression profiles in developing B cells of murine bone marrowBCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasionBeyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitroPhysical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic proteinMCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthoodMechanistic rationale for MCL1 inhibition during androgen deprivation therapy.DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosisα-Mangostin, a Natural Agent, Enhances the Response of NRAS Mutant Melanoma to Retinoic Acid.Dynamic Bcl-xL (S49) and (S62) Phosphorylation/Dephosphorylation during Mitosis Prevents Chromosome Instability and Aneuploidy in Normal Human Diploid FibroblastsThe protein kinase C delta catalytic fragment targets Mcl-1 for degradation to trigger apoptosis.Effects of siRNA-mediated silencing of myeloid cell leukelia-1 on the biological behaviors and drug resistance of gastric cancer cells.Proteomic dissection of DNA polymerization.Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis.Embryonic lethality of fortilin-null mutant mice by BMP-pathway overactivationWRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.Bcl-xL is an oncogenic driver in colorectal cancer.Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival.Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survivalIdelalisib and bendamustine combination is synergistic and increases DNA damage response in chronic lymphocytic leukemia cells.Regulation of anti-apoptotic BCL2-proteins by non-canonical interactions: the next step forward or two steps back?Potential Antitumor Activity and Apoptosis Induction of Glossostemon bruguieri Root Extract against Hepatocellular Carcinoma Cells.Intersection of mitochondrial fission and fusion machinery with apoptotic pathways: Role of Mcl-1.Survival control of malignant lymphocytes by anti-apoptotic MCL-1.Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility.A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration.ECRG4 is a negative regulator of caspase-8-mediated apoptosis in human T-leukemia cells.
P2860
Q21145296-32995C0A-995D-4247-A8D4-CC5386363F90Q24291790-6948D7AD-D1A3-47B5-BAC4-CCCAFDA94993Q24312475-8143217F-795B-4B4F-BE65-3ED963C31F77Q24595974-6F5A5FF5-AD1B-4830-85A8-0CF3C849C92CQ28119158-0B346B74-75B7-4469-9816-FABE0ED60A52Q28216425-D27A2AB8-F481-4000-9C37-272090618DBEQ28217147-8572CD37-FC3A-4361-9694-F0AFD2A223B0Q28217331-99481D1C-F15B-461A-B2C9-F1F48D256320Q28484291-7BACE747-F7FD-4C64-A0FB-E0666367B829Q28484905-C2A9D991-D634-4781-BDE7-5035C5CA5112Q28542827-9352F0D2-5B1D-47E1-A189-6AD05B1AF8F5Q34047415-177E2683-CAF6-4696-9F3F-82B65F9EE9ECQ34582160-F947A73A-4189-425D-AEEF-298D0046EEADQ34991284-66B112FB-6F7C-4AB9-AFDA-09A94312B096Q35003032-A918BDCB-8F1C-445B-A2E4-6BBD2714F160Q35006788-3079AEF8-C249-423E-A0F4-276560617A90Q35009440-9D839171-BD12-49FC-8BC9-7456E0421D41Q35213271-D3A1E53E-6196-4D7C-90B1-30C9BE9D93D5Q35238129-5BA34523-EF4F-43AD-8D1B-F0751FAD7E67Q35742477-189D9ED4-5269-408F-9C07-A5CCDCD80378Q35815150-2C8A53B8-2C23-465B-9059-07EF442F7DF7Q35996844-A5130EF9-C22E-4AEC-9A3A-04307749EF6CQ36072488-F2227C97-1586-4D7B-9914-8F8D0C6A8423Q36391071-D0D026D2-46F8-4149-9D9D-FC834A0E81FEQ36420278-B986D6BC-3E8B-4D08-8291-D64AA2000F4EQ36445573-4E08C723-5F13-4BE0-9828-51C8ACE8BBDEQ36574003-A33EEFD5-5035-4F1B-ACD8-638A0C4D0717Q37226391-9EF640B8-6B2F-4AC4-9B44-4AE61A082125Q37405945-BA486D0A-337C-4CF0-80F5-390652CFBFB8Q37412492-7F2B3AD6-9F61-40A4-9665-21E36DB1C703Q37420038-D3BA6514-37BF-4AD6-8BC2-2BB784784C98Q37688278-6D623466-312A-41EF-81C3-C7F62632E9FBQ37725415-6ECD49A5-C44D-4353-A6E1-F7CE321E75CFQ37928566-D35D67BD-E2BB-4B6A-A6AF-51ED8918BF27Q38831293-7BB4F103-8939-4670-990E-32E0C7FBDD33Q38846360-F8AEB688-AD08-45B8-A3A6-A5B52BCCC36EQ38914858-3929A64F-EEC2-4C5B-8277-2E00A15D2C32Q38992736-1568A123-C1C0-420B-BD81-423E74788D1CQ39122729-97113388-A5B8-469A-AD6F-FF0098E20508Q39380916-9BF7B108-E5B8-4482-ACFC-C4AE5EF45157
P2860
Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@ast
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@en
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@nl
type
label
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@ast
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@en
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@nl
prefLabel
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@ast
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@en
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@nl
P2093
P2860
P3181
P356
P1476
Regulation of apoptosis and ce ...... iferating cell nuclear antigen
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.M006626200
P407
P577
2000-12-15T00:00:00Z